To assess the cDC phenotype and functionality upon oHSV1-FLT3L treatment, we cultured purified BDCA-1+/BDCA-3+ cDCs along with the supernatant of cancer cell lines treated with oHSV1-FLT3L (MOI of 1) during 24 or 48 h. This evidence concerns the gene CD1C and cancer.